Drug Notebook

Drug Info Tools
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Licensed from
triamcinolone nasal
Page: 1 2 3 Next >
(trye am SIN oh lone)

Uses

Allergic Rhinitis

Symptomatic treatment of seasonal or perennial allergic rhinitis.

Dosage and Administration

General

  • For therapeutic effectiveness, use at regular intervals.

Administration

Intranasal Administration

Administer by nasal inhalation using a metered-dose nasal spray pump.

Shake inhaler gently immediately prior to use.

Prior to initial use, the metered-dose pump spray must be primed with 5 actuations or until a fine mist appears. Prime pump after a period of nonuse (i.e., > 2 weeks) by actuating once.

Clear nasal passages prior to administration.

Tilt the head slightly forward, insert the spray tip into one nostril, and point the tip toward the back of the nose. Pump the drug into one nostril while holding the other nostril closed and concurrently inspire through the nose. Repeat this procedure for the other nostril.

Dosage

After priming, nasal spray pump delivers about 55 mcg of triamcinolone acetonide per metered spray and about 30 or 120 metered doses per 6.5-g or 16.5-g container, respectively.

Once optimal symptomatic relief is achieved, reduce dosage gradually to the lowest effective level.

Intranasal triamcinolone acetonide should not be continued beyond 3 weeks in the absence of adequate symptomatic improvement.

Pediatric Patients

Seasonal Allergic Rhinitis

Intranasal Inhalation

Children 6–11 years of age: Initially 55 mcg (1 spray) in each nostril once daily (110 mcg total). May be increased to 110 mcg (2 sprays) in each nostril once daily (220 mcg total).

Children ≥12 years of age: 110 mcg (2 sprays) in each nostril once daily (220 mcg total).

Perennial Allergic Rhinitis

Intranasal Inhalation

Children 6–12 years of age: Initially 55 mcg (1 spray) in each nostril once daily (110 mcg total). Maximum, 110 mcg (2 sprays) in each nostril once daily (220 mcg total).

Children ≥12 years of age: Initially 110 mcg (2 sprays) in each nostril once daily (220 mcg total).

Adults

Seasonal Allergic Rhinitis

Intranasal Inhalation

110 mcg (2 sprays) in each nostril once daily (220 mcg total).

Perennial Allergic Rhinitis

Intranasal Inhalation

110 mcg (2 sprays) in each nostril once daily (220 mcg total).

Prescribing Limits

Pediatric Patients

Seasonal or Perennial Allergic Rhinitis

Intranasal Inhalation

Children 6–12 years of age: Maximum 220 mcg (2 sprays in each nostril) daily.

Adults

Seasonal or Perennial Allergic Rhinitis

Intranasal Inhalation

Maximum 220 mcg (2 sprays in each nostril) daily.

Perennial Allergic Rhinitis

Intranasal Inhalation

Maximum 220 mcg (2 sprays in each nostril) daily.

Special Populations

Dosage in Hepatic Impairment

No specific dosage recommendations at this time.

Dosage in Renal Impairment

No specific dosage recommendations at this time.

Geriatric Patients

No specific dosage recommendations at this time.

Page: 1 2 3 Next >
Advertisement
Back to Top